Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,266

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pan-pepin-inc-emite-alerta-por-alergenos-en-el-producto-parabien-al-grano-debido-la-presencia-dePublished October 13, 2026

Most affected stateHawaii 200 recalls mention this state

State: VI ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 14, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-4114-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Nexterone (amiodarone HCI), 360 mg/200 mL (1.8 mg/mL) in GALAXY Single-Dose Container, sterile, Nonpyrogenic, iso-osmotic solution in Dextrose, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in the USA, NDC 43066-360-20.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60012 USA, NDC 0338-9640-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 400 mcg per 100 mL (4 mcg/mL) in Galaxy 100 mL Single Dose Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-9557-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-5197-41.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3612-50.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Daptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL Single Dose Container (24 bags/carton), Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0714-24.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48.

by Baxter Healthcare Corporation

Reason: CGMP Deviations
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall United States Ongoing2026 recordClass I

THE HAMPTON GROCER

Product: THE HAMPTON GROCER brand; Lacnola; SMALL BATCH LACTATION GRA…
Reason: Product may be contaminated with Salmonella.
Published: September 9, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. Braun Medical, Inc., Bethlehem, PA 18018-3524 USA, NDC 0264-7750-00

by B BRAUN MEDICAL INC

Reason: Presence of Particulate matter.
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Ramipril Capsules USP, 10 mg, packaged in a) 100 Capsules (NDC 76282-673-01) and b) 500 Capsules (NDC 76282-673-05) bottles, Rx only, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33432, Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228.

by Hikma Pharmaceuticals USA Inc.

Reason: Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, Illinois, 60047, NDC 65219-594-20.

by Fresenius Kabi USA, LLC

Reason: Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3

by Apotex Corp.

Reason: Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2

by Mallinckrodt Hospital Products Inc.

Reason: Presence of particulate matter: glass and stopper piece
Published: September 2, 2026
Distribution: Nationwide

View recall →

Data last updated: October 14, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.